Trump Says He’s ‘Affordability President’ After Historic Deal With Drugmakers
President Donald J. Trump is once again drawing a sharp contrast between his administration’s results and the economic turbulence America endured under Joe Biden, declaring over the weekend that he is now the nation’s “affordability president.” The remark comes as the White House rolls out an aggressive slate of consumer-cost reductions — particularly on prescription drugs — ahead of next year’s midterm elections.
In a series of posts on Truth Social, the president touted the sweeping pricing reforms his administration has forced into the pharmaceutical sector.
“Because I have invoked FAVORED NATIONS STATUS FOR THE UNITED STATES OF AMERICA, DRUG PRICES ARE FALLING AT LEVELS NEVER SEEN BEFORE, 500%, 600%, 700%, and more,” Trump wrote. “No other President has been able to do this, BUT I HAVE! This is also the answer to much less expensive, and far better, HEALTHCARE!
“Republicans, remember, this was done by us, and nobody else,” he continued. “This is a revolution in medicine, the biggest and most important event, EVER. If this story is properly told, we should win the Midterm Elections in RECORD NUMBERS. I AM THE AFFORDABILITY PRESIDENT. TALK LOUDLY AND PROUDLY!”
These comments follow a flurry of policy moves designed to reverse the inflationary spiral that erupted under Biden. As Just the News noted, the current administration has taken direct aim at costs for fuel, groceries, and pharmaceuticals — sectors that hit working-class families hardest.
White House officials confirmed that major drug manufacturers have entered new agreements with the administration. Companies such as Novo Nordisk and Eli Lilly have accepted dramatic price reductions on GLP-1 weight-loss drugs, while AstraZeneca will now limit Medicaid prices to ensure Americans do not pay more than consumers overseas. The changes represent one of the largest direct confrontations with Big Pharma in modern presidential history.
Earlier this month, Trump signed a landmark executive order targeting grocery inflation by eliminating tariffs on a range of everyday staples — beef, coffee, tomatoes, bananas, and more. The rollback removes reciprocal duties established under previous trade actions, prioritizing affordability for American households while maintaining pressure on foreign competitors where it matters.
“I have determined that certain agricultural products shall not be subject to the reciprocal tariff imposed [under previous orders],” the directive stated.
The move has triggered an ideological debate among economists who long argued that tariffs contributed to rising prices. But Trump advisers insist the strategy is working exactly as intended: tariffs as leverage, not punishment for American families. The administration’s position is backed by Treasury Secretary Scott Bessent, who explained to Fox News that the changes apply only to goods Americans rely on but cannot produce at home.
“You’re going to see some substantial announcements over the next couple of days in terms of things we don’t grow here in the United States — coffee being one of them, bananas, other fruits, things like that,” Bessent said. “That will bring the prices down very quickly.”
White House Press Secretary Karoline Leavitt has repeatedly emphasized that the president’s trade agenda defends American workers while holding foreign governments accountable. “Tariffs are a tax hike on foreign countries that have been ripping us off,” she stressed earlier this year.
The administration’s updated tariff posture reflects months of negotiations that resulted in new bilateral deals with Argentina, Guatemala, Ecuador, and El Salvador — all aimed at stabilizing prices on foreign produce without sacrificing U.S. strategic advantage.
U.S. Trade Representative Jamieson Greer described the shift as part of the broader Trump doctrine on trade: tough pressure first, tactical relief when American families benefit.
“Now we have a critical mass of agreements with countries who make this stuff, so this is good timing,” Greer told CNBC, underscoring the president’s belief that tariffs are tools — not dogma.
As the midterms approach, Trump’s allies argue that his affordability push highlights a fundamental contrast between his results-driven leadership and the Democratic Party’s messaging-heavy approach to the economy. With prices falling across consumer sectors and pharmaceutical reforms taking hold, the White House is betting heavily that voters will feel the difference.